Plm-102, a Next Generation FLT3 Inhibitor, Shows Potent Anti-Leukemic Activity on Resistance to Gilteritinib in FLT3 Mutated Acute Myeloid Leukemia

被引：0
|
作者：
Lee, Jae-Seon [1 ]
Park, Min Ji [1 ]
Sun, Ningning [1 ]
Park, Jin-Hee [1 ]
Oh, Su-jin [1 ]
Moon, Miran [1 ]
Kim, Myung Jin [1 ]
Jang, Soo Yeon [1 ]
Kim, Yong-Chul [1 ]
机构：
[1] PeLeMed, Seoul, South Korea
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180483
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Crenolanib: A next generation FLT3 inhibitor
    Galanis, Allison
    Rajkhowa, Trivikram
    Muralidhara, Chaitanya
    Ramachandran, Abhijit
    Levis, Mark
    CANCER RESEARCH, 2012, 72
  • [32] An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With FLT3-ITD Mutation, Treated With Gilteritinib, an FLT3 Inhibitor
    Kim, Ryan S.
    Yaghy, Antonio
    Wilde, Lindsay R.
    Shields, Carol L.
    JAMA OPHTHALMOLOGY, 2020, 138 (04) : 418 - 419
  • [33] FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
    Daver, Naval
    Venugopal, Sangeetha
    Ravandi, Farhad
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [34] FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm
    Naval Daver
    Sangeetha Venugopal
    Farhad Ravandi
    Blood Cancer Journal, 11
  • [35] FLT3 Inhibition in Acute Myeloid Leukemia
    Smith, Catherine C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S5 - S6
  • [36] FLT3 inhibitors in acute myeloid leukemia
    Wu, Mei
    Li, Chuntuan
    Zhu, Xiongpeng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [37] FLT3 inhibitors in acute myeloid leukemia
    Mei Wu
    Chuntuan Li
    Xiongpeng Zhu
    Journal of Hematology & Oncology, 11
  • [38] FLT3 Inhibitors in Acute Myeloid Leukemia
    Stone, Richard M.
    ONCOLOGIST, 2016, 21 : S2 - S2
  • [39] GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
    Xinhua Xiao
    Peihong Wang
    Weina Zhang
    Jiayi Wang
    Mansi Cai
    Hua Jiang
    Yingli Wu
    Huizhuang Shan
    Cancer Cell International, 23
  • [40] The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia
    Minson, Katherine A.
    Smith, Catherine C.
    DeRyckere, Deborah
    Libbrecht, Clara
    Lee-Sherick, Alisa B.
    Huey, Madeline G.
    Lasater, Elisabeth A.
    Kirkpatrick, Gregory D.
    Stashko, Michael A.
    Zhang, Weihe
    Jordan, Craig T.
    Kireev, Dmitri
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    Shah, Neil P.
    Graham, Douglas K.
    JCI INSIGHT, 2016, 1 (03)
12345